Algeria approves chloroquine to treat Covid-19 ‘in certain cases’


Algeria has approved the usage of chloroquine by the hospitals in the North African nation to treat patients infected with coronavirus.

According to the statement, the government have specified that the drug should be used to treat “certain cases” of Covid-19, the respiratory illness caused by the virus, in accordance with “specific medical protocol”.

Chloroquine is one of the oldest and best-known anti-malarial drugs – though it is no longer recommended in much of Africa because of the resistance built up to it by the malaria parasites.

In treating malaria patients, the drug has been used to reduce fever and inflammation.

The World Health Organization (WHO) says that so far there is no definitive evidence of its effectiveness when treating Covid-19, but it is part of the continuing trials.

“Chloroquine seems to block the coronavirus in lab studies. There’s some anecdotal evidence from doctors saying it has appeared to help,” says James Gallagher, BBC health correspondent.


Leave a Reply

Your email address will not be published.